Sun Z, Jiang Y, Ma Z, Wu H, Liu B F, Xue Y, Tang W, Chen Y, Li C, Zhu D, Gurewich V, Liu J N
Vascular Research Laboratory, Institute for the Prevention of Cardiovascular Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Biol Chem. 1997 Sep 19;272(38):23818-23. doi: 10.1074/jbc.272.38.23818.
Pro-urokinase has a much higher intrinsic catalytic activity than other zymogens of the serine protease family. Lys300(c143) in an apparent "flexible loop" region (297-313) was previously shown to be an important determinant of this intrinsic catalytic activity. This was related to the loop allowing the positive charge of Lys300(c143) to transiently interact with Asp355(c194), thereby inducing an active conformation of the protease domain (Liu, J. N., Tang, W., Sun, Z., Kung, W., Pannell, R., Sarmientos, P., and Gurewich, V. (1996) Biochemistry 35, 14070-14076). To further test this hypothesis, the charge at position 300(c143) and the flexibility of the loop were altered using site-directed mutagenesis designed according to a computer model to affect the interaction between Lys300(c143) and Asp355(c194). When the charge at Lys300(c143) but not Lys313(c156) was reduced, a significant reduction in the intrinsic catalytic activity occurred. Similarly, when the flexibility (wobbliness) of the loop was enhanced reducing the size of side chain, the intrinsic catalytic activity was also reduced. By contrast, when the loop was made less flexible, the intrinsic catalytic activity was increased. These findings were consistent with the hypothesis. The effects of these mutations on two-chain activity were less and often discordant with the intrinsic catalytic activity, indicating that they can be modulated independently. This structure-function disparity can be exploited to create a more zymogenic pro-urokinase (lower intrinsic catalytic activity) with a high catalytic activity, as exemplified by two of the mutants. The changes in intrinsic catalytic activity and two-chain activity induced by the mutations were due to changes in kcat rather than Km. Some significant structure-function differences between pro-urokinase and its highly homologous counterpart, tissue plasminogen activator, were also found.
尿激酶原比丝氨酸蛋白酶家族的其他酶原具有更高的内在催化活性。先前已表明,在一个明显的“柔性环”区域(297 - 313)中的Lys300(c143)是这种内在催化活性的重要决定因素。这与该环允许Lys300(c143)的正电荷与Asp355(c194)瞬时相互作用有关,从而诱导蛋白酶结构域的活性构象(Liu,J. N.,Tang,W.,Sun,Z.,Kung,W.,Pannell,R.,Sarmientos,P.,和Gurewich,V.(1996)Biochemistry 35,14070 - 14076)。为了进一步验证这一假设,根据计算机模型设计定点诱变来改变300(c143)位的电荷和环的柔性,以影响Lys300(c143)与Asp355(c194)之间的相互作用。当Lys300(c143)而非Lys313(c156)处的电荷减少时,内在催化活性显著降低。同样,当环的柔性(摆动性)增强且侧链尺寸减小时,内在催化活性也降低。相比之下,当环的柔性降低时,内在催化活性增加。这些发现与该假设一致。这些突变对双链活性的影响较小,且常常与内在催化活性不一致,表明它们可以独立调节。这种结构 - 功能差异可用于创建一种具有更高催化活性的更具酶原性的尿激酶原(更低的内在催化活性),如两个突变体所示。突变引起的内在催化活性和双链活性的变化是由于kcat的变化而非Km的变化。还发现了尿激酶原与其高度同源的对应物组织型纤溶酶原激活剂之间一些显著的结构 - 功能差异。